# Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy

> **NCT03593681** · — · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 150 (actual)

## Conditions studied

- Fallopian Tube Cancer
- Ovarian Cancer
- Ovarian Neoplasms
- Ovary Cancer
- Fallopian Tube Neoplasms
- Fallopian Tube Adenocarcinoma
- High Grade Serous Carcinoma
- Peritoneal Carcinoma
- Peritoneal Neoplasms
- Adnexal Mass
- Ovarian Diseases

## Interventions

- **DEVICE:** Hysteroscopic cell sampling of the fallopian tube

## Key facts

- **NCT ID:** NCT03593681
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-27
- **Primary completion:** 2020-02-14
- **Final completion:** 2020-02-14
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03593681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03593681, "Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03593681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*